CLINICAL CORE - CORE B: ABSTRACT The Clinical Core (Core B) plays a pivotal role in the BIOCARD Study. The Clinical Core is responsible for: (1) the re-enrollment of BIOCARD subjects, (2) scheduling subjects for all visits and all study procedures (including clinical/cognitive assessments, lumbar punctures for collection of cerebrospinal fluid, magnetic resonance imaging (MRI) scans, and positron emission tomography scans using Pittsburgh compound B (PiB/PET scans), (3) completion of annual clinical and cognitive assessments, (4) acquisition of ante-mortem autopsy approval, (5) implementation of subject retention activities, (6) analyses of clinical and cognitive data concerning the study participants, (7) working collaboratively with the other Cores to examine combinations of biomarkers that are predictive of progression and to examine the order and pattern of biomarker change during preclinical AD, and (8) sharing of clinical and cognitive data with investigators in the field via the BIOCARD website, using the approved BIOCARD Study data sharing procedures.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program--Cooperative Agreements (U19)
Project #
2U19AG033655-06
Application #
8740110
Study Section
Special Emphasis Panel (ZAG1-ZIJ-5 (M3))
Project Start
2014-08-15
Project End
2019-03-31
Budget Start
2014-08-15
Budget End
2015-03-31
Support Year
6
Fiscal Year
2014
Total Cost
$1,091,668
Indirect Cost
$417,799
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Sathe, Gajanan; Na, Chan Hyun; Renuse, Santosh et al. (2018) Phosphotyrosine profiling of human cerebrospinal fluid. Clin Proteomics 15:29
Hinkle, Jared T; Perepezko, Kate; Bakker, Catherine C et al. (2018) Domain-specific cognitive impairment in non-demented Parkinson's disease psychosis. Int J Geriatr Psychiatry 33:e131-e139
Chan, Carol K; Soldan, Anja; Pettigrew, Corinne et al. (2018) Depressive symptoms in relation to clinical symptom onset of mild cognitive impairment. Int Psychogeriatr :1-9
Albert, Marilyn; Zhu, Yuxin; Moghekar, Abhay et al. (2018) Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years. Brain :
Blauwendraat, Cornelis; Pletnikova, Olga; Geiger, Joshua T et al. (2018) Genetic analysis of neurodegenerative diseases in a pathology cohort. Neurobiol Aging :
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Hohman, Timothy J; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol 75:989-998
Soldan, Anja; Pettigrew, Corinne; Albert, Marilyn (2018) Evaluating Cognitive Reserve Through the Prism of Preclinical Alzheimer Disease. Psychiatr Clin North Am 41:65-77
Chiang, Angie C A; Fowler, Stephanie W; Reddy, Rohit et al. (2018) Discrete Pools of Oligomeric Amyloid-? Track with Spatial Learning Deficits in a Mouse Model of Alzheimer Amyloidosis. Am J Pathol 188:739-756
Gross, Alden L; Hassenstab, Jason J; Johnson, Sterling C et al. (2017) A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium. Alzheimers Dement (Amst) 8:147-155

Showing the most recent 10 out of 52 publications